Health Policy Advisory Committee
A panel of leaders in health policy from industry, government, academia, consulting, and professional associations provides ongoing guidance to the program. Members include:
David A. Asch, MD, MBA
Executive Director
Leonard Davis Institute of Health Economics
University of Pennsylvania
Philadelphia, PA
Marc L. Berger, MD
Vice President
Outcomes Research & Management
Merck & Co., Inc.
West Point, PA
Glenna M. Crooks, PhD
President and CEO
Strategic Health Policy International, Inc.
Ft. Washington, PA
Robert G. Cuzzolino, ED
Associate Dean for Academic Administration
Philadelphia College of Osteopathic Medicine
Philadelphia, PA
James M. Friedman
Deputy Director
Alliance for Aging Research
Washington, DC
Jean Paul Gagnon, PhD
Director, Health Policy
Aventis Pharmaceuticals, Inc.
Parsippany, NJ
Donald Liss, MD
Senior Patient Management Medical Director
Aetna/U.S. Healthcare
Blue Bell, PA
Henri R. Manasse, Jr., PhD
Executive Vice President and Chief Executive Officer
American Society of Health-System Pharmacists
Washington, DC
Ronald C. Miller, MBA
Senior Director, U.S. Policy & Advocacy
Bristol-Myers Squibb Company
Princeton, NJ
Margaret A. Murray
Executive Director
Association of Health Center Affiliated Health Plans
Washington, DC
David B. Nash, MD, MBA
The Dr. Raymond C. and Doris N. Grandon Professor of
Health Policy
Director, Office of Health Policy & Clinical Outcomes
Jefferson Medical College
Philadelphia, PA
Gerry Oster, PhD
Policy Analysis, Inc.
Brookline, MA
Arnold J. Rosoff, JD
Professor of Legal Studies and Health Care Systems
The Wharton School
University of Pennsylvania
Philadelphia, PA
Jo Surpin
President
Strategic Health Alliance, LLC
Cherry Hill, NJ
